Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-29 Purchase | 2022-08-02 5:02 pm | Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer | 39,382 | $4.25 | $167,374 | 958,446 (Indirect Direct) | View |
| 2022-07-26 Purchase | 2022-07-28 7:52 pm | Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer | 8,618 | $4.2436 | $36,571 | 919,064 (Indirect Direct) | View |
| 2022-07-22 Purchase | 2022-07-26 7:38 pm | Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer | 9,444 | $3.7497 | $35,412 | 910,446 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-25 Option Award | 2024-03-28 12:38 pm | 2025-03-25 2034-03-25 | ESSA Pharma Inc. | EPIX | Requadt Scott Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-10-30 Other | 2024-01-16 1:41 pm | N/A N/A | ESSA Pharma Inc. | EPIX | Requadt Scott Director | 30,002 | $0 | 60,004 (Direct) | View |
| 2023-07-03 Tax Withholding | 2023-07-06 5:19 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Requadt Scott Former Chief Executive Officer | 11,786 | $3.08 | 1,028,169 (Direct) | View |
| 2022-12-30 Option Award | 2023-02-03 5:01 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer | 4 | $0.867 | 1,679,959 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:01 pm | N/A 2033-02-01 | Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer | 640,000 | $0 | 1,679,959 (Direct) | View |
| 2022-06-29 Option Award | 2022-11-01 11:07 am | N/A 2032-06-29 | ESSA Pharma Inc. | EPIX | Requadt Scott Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-09-10 Option Award | 2022-09-13 4:30 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer | 80,000 | $0 | 1,039,955 (Direct) | View |
| 2021-12-31 Option Award | 2022-02-02 6:01 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer | 1,470 | $13 | 1,401,002 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 6:01 pm | N/A 2032-01-31 | Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer | 500,000 | $0 | 1,401,002 (Direct) | View |
Ownership | 2021-05-06 9:25 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Requadt Scott See Remarks | 0 | $0 | 1,596,050 (Direct) | View |
| 2020-12-11 Option Award(A) | 2021-01-26 7:02 pm | N/A 2030-12-11 | ESSA Pharma Inc. | EPIX | Requadt Scott Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2020-12-11 Option Award | 2021-01-11 4:45 pm | N/A 2030-12-11 | ESSA Pharma Inc. | EPIX | Requadt Scott Director | 16,500 | $0 | 16,500 (Direct) | View |
Ownership | 2020-10-01 6:38 pm | N/A N/A | ESSA Pharma Inc. | EPIX | Requadt Scott Director | 0 | $0 | 92,500 (Direct) | View |